These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 17289018)

  • 1. Expression of TGF-beta1, TbetaRII and Smad4 in colorectal carcinoma.
    Xu WQ; Jiang XC; Zheng L; Yu YY; Tang JM
    Exp Mol Pathol; 2007 Jun; 82(3):284-91. PubMed ID: 17289018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus.
    Natsugoe S; Xiangming C; Matsumoto M; Okumura H; Nakashima S; Sakita H; Ishigami S; Baba M; Takao S; Aikou T
    Clin Cancer Res; 2002 Jun; 8(6):1838-42. PubMed ID: 12060625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of expression of TGF-beta1, TbetaRI, and TbetaRII correlates with differentiation in human oral squamous cell carcinomas.
    Mincione G; Di Marcantonio MC; Artese L; Vianale G; Piccirelli A; Piccirilli M; Perrotti V; Rubini C; Piattelli A; Muraro R
    Int J Oncol; 2008 Feb; 32(2):323-31. PubMed ID: 18202754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Smad4 and TGF-beta2 in colorectal carcinoma.
    Kouvidou Ch; Latoufis C; Lianou E; Kouvatseas G; Kakouri E; Anagnostakis D; Vrettou-Aravani V; Betsi E; Karatapanis S
    Anticancer Res; 2006; 26(4B):2901-7. PubMed ID: 16886611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smad4 and ERK2 stimulated by transforming growth factor beta1 in rhabdomyosarcoma.
    Guo H; Zhang HY; Wang SL; Ye L; Yang GH; Bu H
    Chin Med J (Engl); 2007 Mar; 120(6):515-21. PubMed ID: 17439748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of transforming growth factors in hepatocellular carcinoma and its relations with clinicopathological parameters and prognosis.
    Lu Y; Wu LQ; Li CS; Wang SG; Han B
    Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):174-8. PubMed ID: 18397854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of transforming growth factor-beta type II receptor reduces tumorigenicity in the human adrenocortical carcinoma SW-13 cell line.
    Yamamoto N; Imai J; Watanabe M; Hiroi N; Sugano S; Yoshino G
    Horm Metab Res; 2006 Mar; 38(3):159-66. PubMed ID: 16673206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Smad4 and TGF-beta1 expression and clinical significance in bladder transitional cell carcinoma].
    Tang ZY; Yang LY; Zhang YJ; Peng KL; Qi L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):363-6. PubMed ID: 16859125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant overexpression of cyclooxygenase-2 in HER-2-positive on Smad4-reduced human gastric carcinomas is associated with a poor patient outcome.
    Okano H; Shinohara H; Miyamoto A; Takaori K; Tanigawa N
    Clin Cancer Res; 2004 Oct; 10(20):6938-45. PubMed ID: 15501972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preserved Smad4 expression in the transforming growth factor beta signaling pathway is a favorable prognostic factor in patients with advanced gastric cancer.
    Xiangming C; Natsugoe S; Takao S; Hokita S; Ishigami S; Tanabe G; Baba M; Kuroshima K; Aikou T
    Clin Cancer Res; 2001 Feb; 7(2):277-82. PubMed ID: 11234879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased TGF-beta 1 protein expression in patients with advanced colorectal cancer.
    Langenskiöld M; Holmdahl L; Falk P; Angenete E; Ivarsson ML
    J Surg Oncol; 2008 Apr; 97(5):409-15. PubMed ID: 18176914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Smad7 in hepatocellular carcinoma and dysplastic nodules: resistance mechanism to transforming growth factor-beta.
    Park YN; Chae KJ; Oh BK; Choi J; Choi KS; Park C
    Hepatogastroenterology; 2004; 51(56):396-400. PubMed ID: 15086168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of interferon gamma treatment on expression of TGF-beta1 and its receptors in liver fibrosis of mice with schistosomiasis japonica].
    Zhang BB; Jiao YW; Cai WM; Tao J; Liu RH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Dec; 22(6):340-3. PubMed ID: 15830858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta signaling is disrupted in endometrioid-type endometrial carcinomas.
    Piestrzeniewicz-Ulanska D; Brys M; Semczuk A; Rechberger T; Jakowicki JA; Krajewska WM
    Gynecol Oncol; 2004 Oct; 95(1):173-80. PubMed ID: 15385128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in Smad4 expression in human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck squamous cell carcinoma.
    Báez A; Cantor A; Fonseca S; Marcos-Martinez M; Mathews LA; Muro-Cacho CA; Muñoz-Antonia T
    Clin Cancer Res; 2005 May; 11(9):3191-7. PubMed ID: 15867212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of secretory leukocyte proteinase inhibitor in human bronchial epithelial cell is downregulated by transforming growth factor-beta1/Smads pathway].
    Niu RC; Luo BL; Hu CP; Feng JT
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2117-21. PubMed ID: 19080472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human malignant thyroid tumors displayed reduced levels of transforming growth factor beta receptor type II messenger RNA and protein.
    Lazzereschi D; Ranieri A; Mincione G; Taccogna S; Nardi F; Colletta G
    Cancer Res; 1997 May; 57(10):2071-6. PubMed ID: 9158007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased Smad4 expression in the transforming growth factor-beta signaling pathway during progression of esophageal squamous cell carcinoma.
    Fukuchi M; Masuda N; Miyazaki T; Nakajima M; Osawa H; Kato H; Kuwano H
    Cancer; 2002 Aug; 95(4):737-43. PubMed ID: 12209716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-β1 inhibits the growth and metastasis of tongue squamous carcinoma cells through Smad4.
    Wang X; Sun W; Zhang C; Ji G; Ge Y; Xu Y; Zhao Y
    Gene; 2011 Oct; 485(2):160-6. PubMed ID: 21726607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.